Obesity Management Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: O9C1DA464006EN
Market Monitor Global

Abstracts

Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability.

This report contains market size and forecasts of Obesity Management in Global, including the following market information:

Global Obesity Management Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Obesity Management market was valued at 5695.6 million in 2021 and is projected to reach US$ 7781.1 million by 2028, at a CAGR of 4.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Obesity Management include Roche, GlaxoSmithKline, Orexigen Therapeutics, Arena Pharmaceuticals, VIVUS and Novo Nordisk, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Obesity Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Obesity Management Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Obesity Management Market Segment Percentages, by Type, 2021 (%)

• Drug
• Surgery

Global Obesity Management Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Obesity Management Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Speciality Clinics
• Ambulatory Surgical Centres
• Retail Pharmacies

Global Obesity Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Obesity Management Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Obesity Management revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Obesity Management revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• GlaxoSmithKline
• Orexigen Therapeutics
• Arena Pharmaceuticals
• VIVUS
• Novo Nordisk

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Obesity Management Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Obesity Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OBESITY MANAGEMENT OVERALL MARKET SIZE

2.1 Global Obesity Management Market Size: 2021 VS 2028
2.2 Global Obesity Management Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Obesity Management Players in Global Market
3.2 Top Global Obesity Management Companies Ranked by Revenue
3.3 Global Obesity Management Revenue by Companies
3.4 Top 3 and Top 5 Obesity Management Companies in Global Market, by Revenue in 2021
3.5 Global Companies Obesity Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Obesity Management Players in Global Market
  3.6.1 List of Global Tier 1 Obesity Management Companies
  3.6.2 List of Global Tier 2 and Tier 3 Obesity Management Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Obesity Management Market Size Markets, 2021 & 2028
  4.1.2 Drug
  4.1.3 Surgery
4.2 By Type - Global Obesity Management Revenue & Forecasts
  4.2.1 By Type - Global Obesity Management Revenue, 2017-2022
  4.2.2 By Type - Global Obesity Management Revenue, 2023-2028
  4.2.3 By Type - Global Obesity Management Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Obesity Management Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Speciality Clinics
  5.1.4 Ambulatory Surgical Centres
  5.1.5 Retail Pharmacies
5.2 By Application - Global Obesity Management Revenue & Forecasts
  5.2.1 By Application - Global Obesity Management Revenue, 2017-2022
  5.2.2 By Application - Global Obesity Management Revenue, 2023-2028
  5.2.3 By Application - Global Obesity Management Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Obesity Management Market Size, 2021 & 2028
6.2 By Region - Global Obesity Management Revenue & Forecasts
  6.2.1 By Region - Global Obesity Management Revenue, 2017-2022
  6.2.2 By Region - Global Obesity Management Revenue, 2023-2028
  6.2.3 By Region - Global Obesity Management Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Obesity Management Revenue, 2017-2028
  6.3.2 US Obesity Management Market Size, 2017-2028
  6.3.3 Canada Obesity Management Market Size, 2017-2028
  6.3.4 Mexico Obesity Management Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Obesity Management Revenue, 2017-2028
  6.4.2 Germany Obesity Management Market Size, 2017-2028
  6.4.3 France Obesity Management Market Size, 2017-2028
  6.4.4 U.K. Obesity Management Market Size, 2017-2028
  6.4.5 Italy Obesity Management Market Size, 2017-2028
  6.4.6 Russia Obesity Management Market Size, 2017-2028
  6.4.7 Nordic Countries Obesity Management Market Size, 2017-2028
  6.4.8 Benelux Obesity Management Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Obesity Management Revenue, 2017-2028
  6.5.2 China Obesity Management Market Size, 2017-2028
  6.5.3 Japan Obesity Management Market Size, 2017-2028
  6.5.4 South Korea Obesity Management Market Size, 2017-2028
  6.5.5 Southeast Asia Obesity Management Market Size, 2017-2028
  6.5.6 India Obesity Management Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Obesity Management Revenue, 2017-2028
  6.6.2 Brazil Obesity Management Market Size, 2017-2028
  6.6.3 Argentina Obesity Management Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Obesity Management Revenue, 2017-2028
  6.7.2 Turkey Obesity Management Market Size, 2017-2028
  6.7.3 Israel Obesity Management Market Size, 2017-2028
  6.7.4 Saudi Arabia Obesity Management Market Size, 2017-2028
  6.7.5 UAE Obesity Management Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Obesity Management Major Product Offerings
  7.1.4 Roche Obesity Management Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Obesity Management Major Product Offerings
  7.2.4 GlaxoSmithKline Obesity Management Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Orexigen Therapeutics
  7.3.1 Orexigen Therapeutics Corporate Summary
  7.3.2 Orexigen Therapeutics Business Overview
  7.3.3 Orexigen Therapeutics Obesity Management Major Product Offerings
  7.3.4 Orexigen Therapeutics Obesity Management Revenue in Global Market (2017-2022)
  7.3.5 Orexigen Therapeutics Key News
7.4 Arena Pharmaceuticals
  7.4.1 Arena Pharmaceuticals Corporate Summary
  7.4.2 Arena Pharmaceuticals Business Overview
  7.4.3 Arena Pharmaceuticals Obesity Management Major Product Offerings
  7.4.4 Arena Pharmaceuticals Obesity Management Revenue in Global Market (2017-2022)
  7.4.5 Arena Pharmaceuticals Key News
7.5 VIVUS
  7.5.1 VIVUS Corporate Summary
  7.5.2 VIVUS Business Overview
  7.5.3 VIVUS Obesity Management Major Product Offerings
  7.5.4 VIVUS Obesity Management Revenue in Global Market (2017-2022)
  7.5.5 VIVUS Key News
7.6 Novo Nordisk
  7.6.1 Novo Nordisk Corporate Summary
  7.6.2 Novo Nordisk Business Overview
  7.6.3 Novo Nordisk Obesity Management Major Product Offerings
  7.6.4 Novo Nordisk Obesity Management Revenue in Global Market (2017-2022)
  7.6.5 Novo Nordisk Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Obesity Management Market Opportunities & Trends in Global Market
Table 2. Obesity Management Market Drivers in Global Market
Table 3. Obesity Management Market Restraints in Global Market
Table 4. Key Players of Obesity Management in Global Market
Table 5. Top Obesity Management Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Obesity Management Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Obesity Management Revenue Share by Companies, 2017-2022
Table 8. Global Companies Obesity Management Product Type
Table 9. List of Global Tier 1 Obesity Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Obesity Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Obesity Management Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Obesity Management Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Obesity Management Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Obesity Management Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Obesity Management Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Obesity Management Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Obesity Management Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Obesity Management Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Obesity Management Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Obesity Management Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Obesity Management Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Obesity Management Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Obesity Management Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Obesity Management Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Obesity Management Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Obesity Management Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Obesity Management Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Obesity Management Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Obesity Management Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Obesity Management Product Offerings
Table 32. Roche Obesity Management Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Obesity Management Product Offerings
Table 35. GlaxoSmithKline Obesity Management Revenue (US$, Mn), (2017-2022)
Table 36. Orexigen Therapeutics Corporate Summary
Table 37. Orexigen Therapeutics Obesity Management Product Offerings
Table 38. Orexigen Therapeutics Obesity Management Revenue (US$, Mn), (2017-2022)
Table 39. Arena Pharmaceuticals Corporate Summary
Table 40. Arena Pharmaceuticals Obesity Management Product Offerings
Table 41. Arena Pharmaceuticals Obesity Management Revenue (US$, Mn), (2017-2022)
Table 42. VIVUS Corporate Summary
Table 43. VIVUS Obesity Management Product Offerings
Table 44. VIVUS Obesity Management Revenue (US$, Mn), (2017-2022)
Table 45. Novo Nordisk Corporate Summary
Table 46. Novo Nordisk Obesity Management Product Offerings
Table 47. Novo Nordisk Obesity Management Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Obesity Management Segment by Type in 2021
Figure 2. Obesity Management Segment by Application in 2021
Figure 3. Global Obesity Management Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Obesity Management Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Obesity Management Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Obesity Management Revenue in 2021
Figure 8. By Type - Global Obesity Management Revenue Market Share, 2017-2028
Figure 9. By Application - Global Obesity Management Revenue Market Share, 2017-2028
Figure 10. By Region - Global Obesity Management Revenue Market Share, 2017-2028
Figure 11. By Country - North America Obesity Management Revenue Market Share, 2017-2028
Figure 12. US Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Obesity Management Revenue Market Share, 2017-2028
Figure 16. Germany Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 17. France Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Obesity Management Revenue Market Share, 2017-2028
Figure 24. China Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 28. India Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Obesity Management Revenue Market Share, 2017-2028
Figure 30. Brazil Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Obesity Management Revenue Market Share, 2017-2028
Figure 33. Turkey Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Obesity Management Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Obesity Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Obesity Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Orexigen Therapeutics Obesity Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Arena Pharmaceuticals Obesity Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. VIVUS Obesity Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novo Nordisk Obesity Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)